HEMATOLOGY

Latest News

Treatment Failure in CML: Distinguishing Between Disease Resistance and Treatment Intolerance
Treatment Failure in CML: Distinguishing Between Disease Resistance and Treatment Intolerance

June 13th 2024

Patients with chronic myeloid leukemia can have a near-normal life expectation when treated with BCR::ABL1 tyrosine kinase inhibitors.

SL-172154 Gains FDA Orphan Drug Designation in Acute Myeloid Leukemia
SL-172154 Gains FDA Orphan Drug Designation in Acute Myeloid Leukemia

June 11th 2024

FDA Clears Phase 1 Study of Lomonitinib for R/R AML Treatment in the US
FDA Clears Phase 1 Study of Lomonitinib for R/R AML Treatment in the US

June 10th 2024

FDA Oks Imetelstat in Lower-Risk MDS With Transfusion-Dependent Anemia
FDA Oks Imetelstat in Lower-Risk MDS With Transfusion-Dependent Anemia

June 7th 2024

How to Handle CLS From Tagraxofusp and Maintain Treatment in BPDCN
How to Handle CLS From Tagraxofusp and Maintain Treatment in BPDCN

June 5th 2024